Misplaced Pages

Suvratoxumab

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Monoclonal antibody Pharmaceutical compound
Suvratoxumab
Monoclonal antibody
Type?
SourceHuman
TargetStaphylococcus aureus alpha toxin
Clinical data
Other namesMEDI4893
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC6556H10114N1730O2100S44
Molar mass148179.68 g·mol

Suvratoxumab (INN; development code MEDI4893) is a human monoclonal antibody designed for the prevention of nosocomial pneumonia caused by Staphylococcus aureus.

This drug was developed by MedImmune

References

  1. World Health Organization (2016). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 116" (PDF). WHO Drug Information. 30 (4).
  2. Statement On A Nonproprietary Name Adopted By The USAN Council - Suvratoxumab, American Medical Association.
Stub icon

This monoclonal antibody–related article is a stub. You can help Misplaced Pages by expanding it.

Monoclonal antibodies for infectious disease and toxins
Fungal
Human
Viral
Human
Chimeric
Humanized
Bacterial
Human
Mouse
Chimeric
Humanized
Toxin
Human
Chimeric
Humanized
Categories: